News

FDA Wants Suicide Warnings On Epilepsy Drugs
A panel of independent experts that advises the US Food and Drug Administration (FDA) is meeting this Thursday in Beltsville, Maryland, to review evidence of increased suicide risk for patients on anti-seizure drugs, and is expected to agree to the FDA's recommendation that these drugs carry the highest level of warning, the so-called "Black Box" label.
Read more...
Diagnostic
Biomedical research product (BMR) & Particle characterization products

Product Group

Flowcytometer & Monoclonal antibody